L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson's Disease

Abstract excerpt

Motor symptoms in Parkinson's disease (PD) are directly related to the reduction of a neurotransmitter dopamine. Therefore, its precursor L-DOPA became the gold standard for PD treatment. However, chronic use of L-DOPA causes uncontrollable, involuntary movements, called L-DOPA-induced dyskinesia (LID) in the majority of PD patients. LID is complicated and very difficult to manage. Current rodent and non-human...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autism Spectrum Disorder Research
• Share to Neuroscience and Neuropharmacology Research
• Share to Parkinson's Disease Mechanisms and Treatments